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Abstract
Background: Zebrafish (Danio rerio), due to its optical accessibility and similarity to human, has
emerged as model organism for cardiac research. Although various methods have been developed
to assess cardiac functions in zebrafish embryos, there lacks a method to assess heartbeat regularity
in blood vessels. Heartbeat regularity is an important parameter for cardiac function and is
associated with cardiotoxicity in human being. Using stereomicroscope and digital video camera,
we have developed a simple, noninvasive method to measure the heart rate and heartbeat
regularity in peripheral blood vessels. Anesthetized embryos were mounted laterally in agarose on
a slide and the caudal blood circulation of zebrafish embryo was video-recorded under
stereomicroscope and the data was analyzed by custom-made software. The heart rate was
determined by digital motion analysis and power spectral analysis through extraction of frequency
characteristics of the cardiac rhythm. The heartbeat regularity, defined as the rhythmicity index,
was determined by short-time Fourier Transform analysis.
Results: The heart rate measured by this noninvasive method in zebrafish embryos at 52 hour
post-fertilization was similar to that determined by direct visual counting of ventricle beating (p >
0.05). In addition, the method was validated by a known cardiotoxic drug, terfenadine, which affects
heartbeat regularity in humans and induces bradycardia and atrioventricular blockage in zebrafish.
A significant decrease in heart rate was found by our method in treated embryos (p < 0.01).
Moreover, there was a significant increase of the rhythmicity index (p < 0.01), which was supported
by an increase in beat-to-beat interval variability (p < 0.01) of treated embryos as shown by
Poincare plot.
Conclusion: The data support and validate this rapid, simple, noninvasive method, which includes
video image analysis and frequency analysis. This method is capable of measuring the heart rate and
heartbeat regularity simultaneously via the analysis of caudal blood flow in zebrafish embryos. With
the advantages of rapid sample preparation procedures, automatic image analysis and data analysis,
this method can potentially be applied to cardiotoxicity screening assay.
Background
In spite of the morphological differences of the heart, the
early function is similar among different model animals
studied, including zebrafish [1-3]. The zebrafish embryo
has been suggested as an ideal model to uncover the
molecular mechanism of cardiac development and to
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identify genes related to congenital cardiac defects in
human [1,4,5]. In addition, although there are differences
between zebrafish embryos and human in responses to
human cardiotoxic drugs, such as the dissociation
between the atrium and ventricle [6,7] in zebrafish
embryos which is not normally observed in adult
humans, recent studies demonstrated that zebrafish still
has some similar physiological responses to those drugs.
Bradycardia, one type of cardiac arrhythmia, was induced
in zebrafish embryos after treated by well-known QT-pro-
longing drugs, such as terfenadine [6,8]. Furthermore, a
zebrafish ortholog, which encoded for potassium ion
channel responsible for ventricular repolarization, was
cloned and showed functional similarity with the human
counterpart [6].
There are several methods to assess cardiac functions in
zebrafish embryos, including the simplest stopwatch
counting [9], micro pressure system [10], Laser Doppler
microscope technique [11] and electrocardiogram [12].
However, all these techniques are labor-intensive, time-
consuming and requires skillful operator to perform the
experiments, and thus limits their applications for large-
scale studies [11], such as drug toxicity evaluation.
Although the new laser-scanning velocimetry [13] can
quantify cardiovascular performance in zebrafish
embryos, a confocal microscope is needed, which is an
expensive equipment and requires skillful operator. More-
over, recent development in digital imaging analysis tools
makes analysis of cardiac functions, such as cardiac out-
put [14-18], traveling speed of the blood cells [19,20], vis-
ualization and analysis of blood cell distribution, blood
cell count and vasculature structure [14,17,21] in trans-
parent zebrafish embryos easier. Recently, Schwerte and
his co-workers had developed a non-invasive method to
assess heart rate variability in zebrafish embryos [22]. In
their method, heart rate was determined from videos of
beating heart. In brief, heart signal was filtered by band-
pass filter and peak was detected by algorithm fitting
quadratic polynomial to signal data. Peak-peak distance
was determined and converted to beat-to-beat frequency
for plotting cardiotachogram. Variation of heart rate was
shown as a prominent scatter around the median values
of the cardiotachogram. However, none of the current
tools is capable of measuring heartbeat rhythm, an impor-
tant parameter for cardiac function, from power spectrum
of heart signal. Cardiac arrhythmia, i.e. disturbance of
heartbeat regularity [23], is associated with cardiotoxicity
effect of drugs and sudden cardiac death [24].
This prompts for a methodology applicable in zebrafish
embryos to evaluate heartbeat regularity. In the present
study, we described a simple, non-invasive methodology
by video-recording under stereomicroscope and analyzing
the video records with our cuctom made software, which
integrated digital motion analysis [20] and power spectral
analysis, to determine the heart rate. Short-time Fourier
Transform (STFT) analysis was then applied to measure
the heartbeat regularity. Furthermore, we verified that
treatment by terfenadine, a cardiac toxic drug which
induces arrhythmia in human, exhibited atrioventricular
blockage in zebrafish embryos as reported previously [6]
and showed irregular heartbeat, with increasing variabil-
ity of heartbeat time interval. The heartbeat regularity in
terfenadine-treated embryos determined from power
spectral analysis was decreased as compared to control
embryos. The results demonstrated that our method is
able to assess the cardiac physiology, in term of heart rate
and rhythmicity, in zebrafish embryos.
Results
Power spectral analysis of caudal circulation in wild type 
embryos
Flow of blood cells is clearly seen inside blood vessels in
zebrafish embryos once the circulation begins at 24 hpf.
The flow is pulsatile, with a rhythm of fast and slow move-
ment. With our image analysis software, this oscillatory
movement of blood cells can be visualized by waveform
of dynamic pixels. A typical example of waveform of
dynamic pixels for a 52 hpf zebrafish embryo is shown in
Figure 1A. The waveform exhibited a rapid upstroke of the
amount of dynamic pixels followed by a drop, showing
the rhythmic change of blood cell velocity. This rhythmic
fluctuation of dynamic pixels was consistent with the
direct observation of pulsatile flow of blood cells
observed under stereo-microscope. Frequency characteri-
zation of this rhythmic flow of blood cells was done by
transforming the waveform in time domain to frequency
domain. Figure 1B showed the corresponding power spec-
trum for the waveform of dynamic pixels. Two peaks of
frequency components (at 2.31 Hz and 4.69 Hz) were
identified. The first peak (2.31 Hz) was the basic fre-
quency (fbasic) component of the waveform of dynamic
pixels. The second frequency component was the multiple
of the first one and should be considered as the harmonic
counterpart of the basic frequency component [25].
Validation of heartbeat frequency detected by the 
program
Cardiac performance in wild type zebrafish embryos (n =
25) at 52 hpf were assessed by both power spectra analysis
and visual examination (Fig. 2A). The mean value of fbasic
was 2.08 and the heart rate was 125.3 ± 11.9 beat per
minute for power spectral analysis. On the other hand, the
mean heart rate determined by direct visual examination
of ventricle beating was 121.6 ± 11.8 beats per minute.
There was no significant difference between them (p >
0.05). There was a linear correlation between the heart
rate determined by visual inspection and by power spec-
tral analysis and the slope of linear regression was approx-BMC Biotechnology 2009, 9:11 http://www.biomedcentral.com/1472-6750/9/11
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imately equal to 1 (Fig. 2B). The results indicated that the
heart rate determined by our method was equivalent to
the heart rate determined by visual counting.
Demonstration with cardiotoxic drug: terfenadine
Terfenadine, a cardiotoxic drug prominently linked to
proarrhythmia in humans, was used as an example.
Recent studies showed that terfenadine induced bradycar-
dia and atrioventricular blockage in zebrafish [6,8].
Videos of caudal circulation in terfenadine-treated
embryos were analyzed with our program. Direct observa-
tion of caudal circulation in terfenadine-treated embryos
showed that movement of blood cells in dorsal aorta was
pulsatile as seen in control embryos. An example of wave-
form of dynamic pixels (Fig. 3A) of a terfenadine-treated
embryo with severe effect and its corresponding power
spectrum (Fig. 3B) were shown. Although the waveform
of dynamic pixels also exhibited oscillatory change of
blood cells velocity along the time being analyzed, the fba-
sic was hard to identify in the power spectrum (Fig. 3B). In
general, the fbasic of terfenadine-treated embryos were just
a peak a little bit higher than other frequency components
and was less dominant in the power spectra, as compared
with the power spectra of control embryos (Fig. 1B).
Terfenadine-treated embryos showed variation of heart
beat, from about 1 Hz to 2.5 Hz. (data not shown). Heart-
beat frequency of complete terfenadine-treated embryos
determined from power spectra was 1.551 ± 0.3633 Hz,
which was significantly slower than control embryos
(2.165 ± 0.0307 Hz; p < 0.01). The computed heart rate
was 93.1 ± 21.8 for terfenadine treatment. We separated
the terfenadine-treated embryos into two groups. One
group included those embryos with heart beat close to 1
A typical example of the signal of dynamic pixels (A) and its  corresponding power spectrum (B) obtained from the caudal  circulation of a 52-hpf control embryo Figure 1
A typical example of the signal of dynamic pixels (A) 
and its corresponding power spectrum (B) obtained 
from the caudal circulation of a 52-hpf control 
embryo. fbasic: first frequency component
(A) Heart rate determined from visual examination of heart  beats from 52 hpf zebrafish embryos is corresponding to the  one determined from power spectral analysis Figure 2
(A) Heart rate determined from visual examination 
of heart beats from 52 hpf zebrafish embryos is cor-
responding to the one determined from power spec-
tral analysis. (B) Linear correlation between the heart beats 
analyzed by power spectrum and visual counting was found.BMC Biotechnology 2009, 9:11 http://www.biomedcentral.com/1472-6750/9/11
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Hz., i.e. bradycardia, while the other group showed nor-
mal heart beat as in control. The heart beat frequency (Fig.
3C) of terfenadine-treated embryos with bradycardia (n =
50) determined from power spectra was 1.198 ± 0.0423
Hz, which was significantly slower than that of control
embryos (n = 60; 2.165 ± 0.0307 Hz; p < 0.01). The com-
puted heart rate was 129.9 ± 11.9 beats per minute for
control and 71.9 ± 21.8 beats per minute for terfenadine
treatment.
Increased variation of heart beat interval by terfenadine
Embryos treated with terfenadine showed a significant
increase in the variation of heart beat interval. Poincare
plot, an emerging quantitative visualization tool, provides
additional information about the variation between
heartbeats. Typical examples for both control (Fig. 4A)
and terfenadine-treated embryos with bradycardia (Fig.
4B) were shown. In control embryo, the plot had concen-
trated data points arranged from 0.3 to 0.6 sec, clustering
around 0.48 sec. In contract, the plot of terfenadine-
treated embryos was dispersed, spreading from 0.3 to 1
sec. Although there was a cluster around 0.48 seconds,
some of data points were diverged from the cluster, mak-
ing the standard deviation large. Variation of heart beat
interval was significantly increased from 0.0615 ± 0.0107
in control embryos to 0.1857 ± 0.0627 in terfenadine
treated embryos (p < 0.01), illustrating the increased vari-
ation of heartbeat by terfenadine in zebrafish embryos.
Short-time Fourier Transform (STFT) analysis
Apart from the poincare plot, the variation of the heart-
beat was also demonstrated by the changes of fbasic time by
time by STFT analysis by our program. Figure 5 illustrated
the changes of frequency by analyzing the signal of
dynamic pixels time by time from control and terfena-
dine-treated embryos. In control embryo (Fig. 5A), the fba-
sic  (red colour) in each second analyzed was kept
consistent along the examination period. However, in ter-
fenadine-treated embryo with bradycardia (Fig. 5B), the
fbasic was changed along time. In addition, some terfena-
dine-treated embryos had shown similar heart rate with
control embryos (Fig. 5C), but the fbasic was also shifted
time by time. The rhythmicity index, as defined by the
coefficient of variation in STFT power spectra, in control
embryos was 0.03421 ± 0.0018 (Fig. 6). The rhythmicity
index of terfenadine-treated embryos (including both
embryos with bradycardia and with normal heart rate)
was 0.07011 ± 0.0047 which was statistically significant
different to the rhythmicity index in control embryos (p <
0.05).
A typical example of the signal of dynamic pixels (A) and its  corresponding power spectrum (B) obtained from the caudal  circulation of terfenadine-treated embryo at 52 hpf Figure 3
A typical example of the signal of dynamic pixels (A) 
and its corresponding power spectrum (B) obtained 
from the caudal circulation of terfenadine-treated 
embryo at 52 hpf. (C) The heart beat frequency of control 
and terfenadine-treated embryos with bradycardia analyzed 
by power spectrum. A significant decrease in heart beat fre-
quency was found in terfenadine-treated embryos (p < 0.01).BMC Biotechnology 2009, 9:11 http://www.biomedcentral.com/1472-6750/9/11
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Discussion
This paper presents a simple and rapid method to analyze
cardiac functions in small transparent animals, like
zebrafish embryos, using video imaging technology.
Sample preparation
Analysis of cardiac performance by digital motion analy-
sis requires immobilization of animal samples because
any movement could result in complication of subse-
quent data analysis. Therefore, immobilization is an
important step for successful acquisition of video images.
Immobilization of zebrafish embryo is commonly
achieved by anesthetization, followed by mounting
embryos in agarose of low concentration. Anesthetization
of embryos was performed by incubation in 0.004% (w/
v) triciane, equivalent to 40 mg/L, at which it was reported
not to exhibit any adverse effect on heart rate and contrac-
tility [6]. The concentration used is lower than other stud-
Poincare plot of time interval of heart beat from (A) control  and (B) terfenadine-treated embryos at 52 hpf Figure 4
Poincare plot of time interval of heart beat from (A) 
control and (B) terfenadine-treated embryos at 52 
hpf. X-axis is the time interval of heart beat at a particular 
time while Y-axis is the time interval of next heart beat. The 
shape and size of cluster illustrates the increase of heart beat 
variability in terfenadine-treated embryos.
Short-time Fourier Transform (STFT) analysis Figure 5
Short-time Fourier Transform (STFT) analysis. The 
figure illustrates the STFT analysis of signal of dynamic pixels 
in every 0.5 sec along time. The time interval for each analy-
sis is 1 sec. Intensity of green colour is corresponding to the 
power value while the red colour indicates the fbasic. (A) 
Control embryo showed consistent fbasic during the examina-
tion period. In contrast, the fbasic varied time by time in ter-
fenadine-treated embryos, no matter in embryo with (B) 
decreased heart rate or (C) normal heart rate.
Effect of terfenadine on heart rate and heart rate variability Figure 6
Effect of terfenadine on heart rate and heart rate 
variability. Bradycardia was induced by terfenadine treat-
ment (A). Rhythmicity index was increased by terfenadine 
treatment (B), suggesting induction of irregularity of heart 
rate by terfenadine.BMC Biotechnology 2009, 9:11 http://www.biomedcentral.com/1472-6750/9/11
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ies have used [15,20], but is sufficient to suppress
spontaneous body movement and successful acquisition
of videos. On the other hand, higher concentrations of
traciane, 50 mg/L [20] and 80 mg/L [15] also did not
affect the cardiac performance in zebrafish embryos after
anesthetization.
After anesthetization, embryos were mounted in low-
melting point agarose at low concentration in order to
hold them in fixed position for video acquisition. Liquid
media is avoided because any fluid flow, even in slow
speed, will cause errors in subsequent video analysis.
Although oxygen equilibration is reduced in agarose, car-
diac activity of zebrafish embryos is not affected as
reported [20].
Positioning of embryos is an important step in the sample
preparation for capturing video. In our preparation, the
spontaneous positioning of zebrafish embryos in lateral
position at the bottom of media facilitates the procedures
for video imaging analysis of caudal blood flow. In addi-
tion, embryo samples prepared for the analysis using the
current method can be oriented in random direction. In
the original procedures of digital motion analysis,
embryos were placed in horizontal position and thus
movement of blood cells was along the axis parallel to the
lines of CCD chip [20]. It was because the shifting vectors
were derived from the sum of all dynamic pixels on hori-
zontal lines. However, in the method presented in this
paper, orientation does not affect the determination of
blood cells velocity because the amount of dynamic pixels
was used, which was relevant to the velocity of blood cells,
although no absolute velocity of blood cells was derived
from the dynamic pixels. Altogether, the procedures of
sample preparation for the presented method are more
effective and less time-consuming.
Milan and his co-works [8] had also used Fourier Trans-
form to determine heart rate in 2-day old zebrafish
embryos. The difference of their method with our present
method is the region of interest. They analyzed the ventri-
cle with Fourier Transform and used ventricular rate as the
index of heart rate. However, as mentioned in Schwerte's
paper [22], heart rate determined by Fourier Transform
was inferred by movement from all tissues around the
heart. Furthermore, in our experience, depending on view
angle, yolk gland (still present at 2-day old embryos)
could cover part of the heart, making analysis of the heart
region with power spectrum analysis of periodic change in
pixel intensity difficult. Therefore, we chose the caudal
part as our region of interest for analysis. At this part, the
only moving objects were blood cells clearly be visualized
inside blood vessels.
Determination of heart rate
Pulsatile movement of blood cell was observed in the cau-
dal vasculature of zebrafish embryos and was revealed in
the waveform pattern of dynamic pixels by our program.
Heart rate determined by power spectral analysis and by
visual counting was not statistically different, suggesting
that the heart rate determined by either method was the
same. In addition, the slope of regression line equals to 1
showed that the heart rates determined by power spectral
analysis and visual counting are equivalent. The advan-
tages of using power spectral analysis include rapid and
full automation during the calculation procedures and
researchers do not need to sit in front of the microscope
to count heartbeat frequency.
To demonstrate the use of power spectral analysis in deter-
mination of heart rate from caudal vasculature, we
applied the method in zebrafish embryos exposed to one
of well known QT-prolonging drugs, terfenadine. Previ-
ous studies demonstrated that QT-prolonging drugs
induced bradycardia in zebrafish embryos, which was
similar to the physiological response in human [6,8]. Sim-
ilarly, our method was also able to detect bradycardia in
terfenadine-treated embryos. In addition to bradycardia,
QT-prolonging drugs examined were able to induce
arrhythmia [6].
Determination of variability of heart beat interval
Rhythm of heartbeats described the regularity of heart
beat. In mammal and avian, rhythmic change of heart rate
is controlled by nervous system, even beginning from the
embryonic stage to adult. For example, the observation of
heart rate irregularities in chicken embryos suggested that
embryonic heart was stimulated by nervous system start-
ing from day 12/13 [26]. However, sudden deviation of
heart rate from its baseline was, sometimes, lethal in
human being. Sudden death was associated with heart
rate arrhythmia [27-29]. For example, variability of QT
interval was higher in dilated cardiomyopathy patients
compared with control persons [30].
Terfenadine affected the ventricle more than the atrium in
zebrafish embryo, resulting in the observation of 2:1 atri-
oventricular blockage. High degree of blockage was
observed at higher concentration or extended incubation
time, sometimes leading to fibrillation and irregular
arrhythmia (i.e. the atrium and ventricle beating irregu-
larly, not in 2:1 fashion) [6]. However, increase in the var-
iability of heart beat interval in zebrafish embryos after
terfenadine treatment was not reported in previous stud-
ies. We had demonstrated the increase of the variation of
heartbeat detected in terfenadine-treated embryos. The
poincare plot showed changes of time interval between
two consecutive heart beats in both control and terfena-BMC Biotechnology 2009, 9:11 http://www.biomedcentral.com/1472-6750/9/11
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dine-treated embryos beat by beat. The STFT analysis illus-
trated the changes of heart rate time by time which was
similar to poincare plot, indicating the ability of our pro-
gram to determine the variation of heart beat frequency.
Moreover, the calculated coefficient of variation from
power spectral analysis, which was determined as rhyth-
micity index, showed that our program was able to detect
the changes of variation of heart rate in zebrafish
embryos.
The variability of heart beat interval was not only deter-
mined from ECG but also from blood pressure. McKinley
and co-workers demonstrated deriving reliable index of
heartbeat variability from peripheral blood pressure
waveform [31]. In their study, peaks and troughs of the
waveform were marked, from which beat-to-beat intervals
were determined. Their results showed that data derived
from blood pressure waveform correspond to the data
determined from ECG. Since determination of heart beat
interval variability depended on the precise identification
of peaks and troughs in waveform data, complex algo-
rithm should be used for automatic detection and analysis
from the data of blood pressure. In our experiments, man-
ual adjustment was sometimes needed for more accurate
determination of peak and trough prior to data analysis.
However, detection of beat peak was not necessary in
power spectral analysis. Instead, variability of beat-to-beat
frequency was determined by the rhythmicity index in our
program. Our results demonstrated that cardiac rhythm
was able to determine from the direct measure of beat-to-
beat interval variability and the power spectral analysis.
The advantage of using power spectral analysis was that
the results were determined from data covering a period of
time of heartbeat and the analysis and determination were
fully automated.
Conclusion
In summary, we have developed a rapid, simple and non-
invasive method to determine the heart rate and heartbeat
regularity from the peripheral circulation of zebrafish
embryo by digital motion analysis and power spectral
analysis. We have demonstrated the ability of our method
in determination of terfenadine-induced bradycardia and
arrhythmia in 52-hpf embryos. With the advantages of
rapid sample preparation procedures, automatic image
analysis and data analysis, this method is applicable to
study the molecular mechanism of variability of heart
beat interval as well as to screen side-effect of cardiotoxic-
ity of non-cardiovascular drugs.
Methods
Fish
Breeding colonies of zebrafish were obtained from local
supplier and were kept in small aquaria according to con-
ditions described in [32]. Briefly, they were kept at 28°C
water and subjected to 14-hour light/10-hour dark cycle.
Spawning occurred when the light was just turn on. Eggs
were collected after 30 minutes of light turning on. Col-
lected eggs were incubated at 28°C in embryo buffer (19.3
mM NaCl, 0.23 mM KCl, 0.13 mM MgSO4·7H2O, 0.2
mM Ca(NO3)2, 1.67 mM Hepes, pH 7.2). At 4-hour post
fertilization (hpf), eggs were examined under dissecting
stereo-microscope (SZX-12, Olympus, Tokyo, Japan).
Dead or unfertilized eggs were removed. Only embryos
which have developed normally and reached the blastula
stage (30% epiboly) were selected for subsequent experi-
ments.
Treatment of cardiotoxic drug
At 4 hpf, 20 embryos were incubated in 6-ml embryo
buffer containing 0.003% (w/v) 1-phenyl-2-thiourea
(PTU) in a Petri dish. PTU at this concentration did not
have any effect on zebrafish embryos except inhibiting the
formation of pigment cells. Terfenadine, a cardiotoxic
drug, was purchased from Sigma. Stock of terfenadine was
prepared by dissolving in dimethyl sulfoxide (DMSO)
with final concentration of 10 mM. At 50 hpf, 6-μl stock
solution of terfenadine were added to 6-ml embryo buffer
to final concentration of 10 μM. The final DMSO concen-
tration in embryo buffer was 0.1% at which did not cause
any adverse effect. Embryos were exposed to terfenadine
for 2 hours prior to video recording.
Imaging of caudal blood circulation
To avoid the movement of zebrafish embryo during vide-
oing, embryos were first anaesthetized by adding tricaine
(MS-222) to embryo buffer at 52 hpf. The final concentra-
tion of tricaine in embryo buffer was 0.004% (w/v) which
did not have any effect on heart beat in zebrafish embryos
[6,21]. Embryos were then mounted laterally in 0.5%
low-melting point agarose. To prevent dry out of agarose
during videoing, a small aliquot of incubated embryo
buffer containing tricaine was added on the top of agar-
ose. Embryos were examined under stereo-microscope
(Olympus) equipped with a 3-color CCD camera
(DC330, Dage-MTI Inc., Michigan City, IN, USA), which
in turn was connected to NTSC digital video recorder
(Sony, Tokyo, Japan) via S-video cable. The video of
blood flowing in caudal region (Fig. 7) was captured at
48× magnification for 1 min. Videos were stored in mini-
DV tapes and were grabbed to personal computer by Mov-
ieMaker (Microsoft, USA) in AVI format.
Digital motion analysis
A custom made program was developed in C# language
(Visual Studio .NET, Microsoft) to implement the method
of digital motion analysis developed by [20]. In brief, a
software frame-grabber, based on the DirectShow devel-
oper tool kit in DirectX version 9 (Microsoft) was used to
grab video frames one by one and convert RGB coloredBMC Biotechnology 2009, 9:11 http://www.biomedcentral.com/1472-6750/9/11
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video frame to gray-scale image. Each image was sub-
tracted by image of consecutive video frame pixel-by-pixel
in gray-scale. The value of static pixels located in non-
moving areas where pixel intensities between 2 images
were not different was zero. Whatever there was difference
in the intensity of particular pixel between 2 images, that
pixel was counted as dynamic pixels and the intensity of
that pixel in subtracted image was assessed as 255. Figure
7B illustrated a typical result after subtraction. To avoid
identification of noise as dynamic pixels, threshold value
of 10 was applied, i.e. the pixel was considered as dynamic
pixel when the intensity difference between 2 images was
greater than 10. Amount of dynamic pixels were expressed
as the percentage to total number of pixels in the images,
i.e. 720 × 480 pixels. Waveform of dynamic pixels was
plotted for each subtracted video frames. Peaks (amax in
Fig. 7C) and troughs (amin in Fig. 7C) of the waveform
were identified automatically in the custom made pro-
gram. The duration between the 2 amin was defined as the
heart beat interval (Fig. 7C) which was equivalent to the
time interval of a complete cycle of systole and diastole of
ventricle.
Power spectral analysis
Waveform of dynamic pixels was analyzed by Fourier
transform (FFT) and power spectral analysis. Transforma-
tion and analysis were implement by C# language (Visual
Studio .NET, Microsoft) using a custom made program.
Function of Fourier transform was implemented by the
derivation of Glassman n-point fast Fourier transform
algorithm [33] which was original written in Fortran lan-
guage. Power spectrum was calculated by power spectrum
estimation algorithm described by [34]. To avoid data
leakage during power spectrum estimation, Welch data
windowing function was applied. Since video was
recorded in frequency of 30 Hz, the maximum frequency,
in principle, was the half of the data acquisition fre-
quency, i.e., 15 Hz. Basic frequency component was calcu-
lated. Before transformation, bandpass filter (0.5 to 5 Hz)
was applied to signal data.
Short-time Fourier Transform (STFT) analysis
Another analysis performed by the custom-made program
is STFT analysis, which is a Fourier-related transform used
to determine the sinusoidal frequency and phase content
of local sections of a signal as it changes over time. Analy-
sis was done on every 0.5 sec and the time interval for each
analysis is 1 sec, i.e., overlapping of 0.5 sec in each ana-
lyzed data segment. Three parameters were calculated,
including mean frequency, which is calculated by summa-
tion of frequency times power value of that frequency,
standard deviation of frequency, which is the variation of
the frequency along time, and the coefficient of variation,
Diagram showing the caudal region of embryo to be analyzed  (A) and the result image of subtraction between 2 consecu- tive video frames (B) with yellow pixels representing the  dynamic pixels Figure 7
Diagram showing the caudal region of embryo to be 
analyzed (A) and the result image of subtraction 
between 2 consecutive video frames (B) with yellow 
pixels representing the dynamic pixels. Schematic dia-
gram illustrated the parameters being analyzed in the signal of 
dynamic pixels (C). amax: maximum value of dynamic pixels; 
amin: minimum value of dyannmic pixels; heart beat interval: 
the time for a complete heart beat between 2 toughs; Scale 
Bar: 50 μm; Right to anterior (head).BMC Biotechnology 2009, 9:11 http://www.biomedcentral.com/1472-6750/9/11
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which is computed by dividing the standard deviation of
frequency by the mean frequency. The coefficient of vari-
ation was reported as the rhythmicity index. The larger the
value of the index, the more the variation of the heart rate
is along time. Data extracted were exported to Excel
(Microsoft) for statistical analysis.
Poincare plot
Poincare plots, correlating observation n  on the x-axis
with observation n+1 on the y-axis, were used to demon-
strat the beat-to-beat variation of the length of cardiac
cycle. The heart beat interval was determined from the
temporal plot of dynamic pixels. Each interval in the
sequence was first n and then n+1 until each interval in the
time series were plotted against its successor.
Statistical analyses
Data were extracted and exported into ASCII text file from
the custom made programs and pre-processed in Excel
(Microsoft, USA). Statistical analyses were performed
using GraphPad Prism 2 (GraphPad Software Inc., San
Diego, CA, USA). Data were presented as mean ± SEM.
Statistical comparison were made with a 2-sample t-test in
2-tail sided. Significance was accepted when p < 0.05. Cor-
relation analysis was performed by Spearman method.
Nonlinear regression analysis was performed with differ-
ent models that compared between each other to find out
the best fit one suggested by Prism.
Abbreviations
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